Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,815 | -21,797 | -120,548 | -103,765 | -76,369 |
| Depreciation Amortization | 2,519 | 1,247 | 5,019 | 3,728 | 2,445 |
| Accounts receivable | 344 | 1,534 | -1,099 | 1,912 | 419 |
| Accounts payable and accrued liabilities | -13,842 | -8,171 | -19,913 | -4,906 | -6,844 |
| Other Working Capital | -17,401 | -8,481 | -44,774 | -30,291 | -31,346 |
| Other Operating Activity | 20,675 | 10,048 | 32,708 | 11,843 | 12,397 |
| Operating Cash Flow | $-52,520 | $-25,620 | $-148,607 | $-121,479 | $-99,298 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,106 | 79,600 | 169,671 | 110,883 | 54,485 |
| PPE Investments | -70 | -70 | -95 | -58 | -55 |
| Purchase Of Investment | N/A | -87,256 | N/A | N/A | N/A |
| Investing Cash Flow | $-15,176 | $-7,726 | $169,576 | $110,825 | $54,430 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 12,529 | 12,529 | N/A |
| Debt Repayment | -643 | -321 | -14,533 | -14,212 | -1,169 |
| Common Stock Issued | N/A | N/A | 732 | 550 | 392 |
| Common Stock Repurchased | -941 | -941 | -972 | -972 | -972 |
| Financing Cash Flow | $-1,584 | $-1,262 | $-2,244 | $-2,105 | $-1,749 |
| Beginning Cash Position | 80,386 | 80,386 | 61,661 | 61,661 | 61,661 |
| End Cash Position | 11,106 | 45,778 | 80,386 | 48,902 | 15,044 |
| Net Cash Flow | $-69,280 | $-34,608 | $18,725 | $-12,759 | $-46,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,520 | -25,620 | -148,607 | -121,479 | -99,298 |
| Capital Expenditure | -70 | -70 | -95 | -58 | -55 |
| Free Cash Flow | -52,590 | -25,690 | -148,702 | -121,537 | -99,353 |